David Singh

22.5k total citations · 1 hit paper
35 papers, 3.3k citations indexed

About

David Singh is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, David Singh has authored 35 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in David Singh's work include Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Cardiac Arrhythmias and Treatments (11 papers) and Atrial Fibrillation Management and Outcomes (7 papers). David Singh is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Cardiac Arrhythmias and Treatments (11 papers) and Atrial Fibrillation Management and Outcomes (7 papers). David Singh collaborates with scholars based in United States, United Kingdom and Spain. David Singh's co-authors include Majid Ezzati, Richard F. Gillum, Young‐Hoon Kim, Mohammad H. Forouzanfar, Mohsen Naghavi, Emelia J. Benjamin, Sumeet S. Chugh, Michiel Rienstra, George A. Mensah and Zhi-Jie Zheng and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

David Singh

30 papers receiving 3.2k citations

Hit Papers

Worldwide Epidemiology of Atrial Fibrillation 2013 2026 2017 2021 2013 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Singh United States 6 3.0k 366 286 248 185 35 3.3k
Rasmus Havmoeller United States 4 3.0k 1.0× 365 1.0× 291 1.0× 251 1.0× 186 1.0× 4 3.3k
Ken Okumura Japan 31 3.8k 1.3× 530 1.4× 353 1.2× 222 0.9× 165 0.9× 208 4.2k
Laila Stærk Denmark 23 2.2k 0.7× 565 1.5× 255 0.9× 168 0.7× 123 0.7× 44 2.5k
Li‐Wei Lo Taiwan 37 3.8k 1.2× 359 1.0× 320 1.1× 259 1.0× 60 0.3× 140 3.9k
Fa‐Po Chung Taiwan 29 2.6k 0.9× 392 1.1× 425 1.5× 137 0.6× 64 0.3× 182 2.9k
Yoko Miyasaka Japan 18 4.1k 1.4× 335 0.9× 373 1.3× 807 3.3× 232 1.3× 42 4.4k
Jelena Kornej Germany 25 2.1k 0.7× 174 0.5× 159 0.6× 239 1.0× 129 0.7× 89 2.5k
Darae Ko United States 19 1.6k 0.5× 157 0.4× 249 0.9× 161 0.6× 127 0.7× 60 2.3k
Mika Lehto Finland 19 1.6k 0.5× 218 0.6× 291 1.0× 189 0.8× 102 0.6× 103 1.9k
Lars Wallentin Sweden 20 1.8k 0.6× 619 1.7× 252 0.9× 209 0.8× 54 0.3× 47 2.2k

Countries citing papers authored by David Singh

Since Specialization
Citations

This map shows the geographic impact of David Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Singh more than expected).

Fields of papers citing papers by David Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Singh. The network helps show where David Singh may publish in the future.

Co-authorship network of co-authors of David Singh

This figure shows the co-authorship network connecting the top 25 collaborators of David Singh. A scholar is included among the top collaborators of David Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Singh. David Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brusselle, Guy, Alberto Papi, J. Christian Virchow, et al.. (2025). Achieving asthma remission with extrafine beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide (BDP/FF/GB) pMDI in adults with moderate-to-severe asthma: A post-hoc analysis of the TRIMARAN and TRIGGER Studies. Journal of Allergy and Clinical Immunology. 155(2). AB235–AB235. 1 indexed citations
2.
Ahuja, Rahul, et al.. (2025). Impact of a care process model on outcomes in emergency department patients with atrial fibrillation. Heart Rhythm O2. 6(10). 1556–1564.
3.
Kreidieh, Omar, Tina D. Hunter, Sandeep Goyal, et al.. (2024). Predictors of first pass isolation of the pulmonary veins in real world ablations: An analysis of 2671 patients from the REAL‐AF registry. Journal of Cardiovascular Electrophysiology. 35(3). 440–450. 4 indexed citations
4.
Oza, Saumil R., Anthony R. Magnano, Mark D. Metzl, et al.. (2024). PO-04-069 ACTIVE VS. PASSIVE ESOPHAGEAL PROTECTION STRATEGIES DURING RADIOFREQUENCY ABLATION OF ATRIAL FIBRILLATION: RESULTS FROM THE PROSPECTIVE REAL-AF REGISTRY. Heart Rhythm. 21(5). S483–S483. 1 indexed citations
6.
Nishimura, Yoshito, et al.. (2023). Cliff diving leading to commotio cordis in a patient with Ebstein's anomaly. Journal of Cardiology Cases. 28(6). 250–252.
7.
Kreidieh, Omar, Allyson L. Varley, Jorge Romero, et al.. (2022). Practice Patterns of Operators Participating in the Real-World Experience of Catheter Ablation for Treatment of Symptomatic Paroxysmal and Persistent Atrial Fibrillation (REAL-AF) Registry. Journal of Interventional Cardiac Electrophysiology. 65(2). 429–440. 7 indexed citations
8.
Voskoboinik, Aleksandr, Edward P. Gerstenfeld, Joshua D. Moss, et al.. (2020). Complex Re-Entrant Arrhythmias Involving the His-Purkinje System. JACC. Clinical electrophysiology. 6(12). 1488–1498. 2 indexed citations
9.
Ortega, Héctor, Mary Fitzgerald, Nihar Bhakta, Kartik Raghupathi, & David Singh. (2019). Reduction of Exhaled Nitric Oxide by the DP2 antagonist GB001 in Patients with Mild Atopic Asthma.. Journal of Allergy and Clinical Immunology. 143(2). AB104–AB104.
10.
Hoffmayer, Kurt S., Frederick T. Han, David Singh, & Melvin M. Scheinman. (2019). Variants of accessory pathways. Pacing and Clinical Electrophysiology. 43(1). 21–29. 13 indexed citations
11.
Singh, David & C. Thomas Peter. (2016). Use of the Surface Electrocardiogram to Define the Nature of Challenging Arrhythmias. Cardiac Electrophysiology Clinics. 8(1). 1–24. 1 indexed citations
12.
Singh, David, et al.. (2015). A RARE CAUSE OF COMPLETE HEART BLOCK. Journal of the American College of Cardiology. 65(10). A767–A767. 1 indexed citations
13.
14.
Chugh, Sumeet S., Rasmus Havmoeller, Kumar Narayanan, et al.. (2013). Worldwide Epidemiology of Atrial Fibrillation. Circulation. 129(8). 837–847. 3197 indexed citations breakdown →
15.
Fitzgerald, Mary, et al.. (2013). The safety, PK and PD profile of ADC3680, a potent and selective CRTh2 antagonist, in healthy volunteers and partly controlled atopic asthmatic subjects. European Respiratory Journal. 42(Suppl 57). P3401–P3401. 4 indexed citations
16.
Singh, David, Eric Bateman, Paul Jones, et al.. (2011). The ATTAIN study: Bronchodilatory effect of aclidinium bromide in chronic obstructive pulmonary disease (COPD). European Respiratory Journal. 38(Suppl 55). p875–p875. 1 indexed citations
17.
Agustí, Àlvar, Paul Jones, Eric Bateman, et al.. (2011). Improvement in symptoms and rescue medication use with aclidinium bromide in patients with chronic obstructive pulmonary disease: Results from ATTAIN. European Respiratory Journal. 38(Suppl 55). p874–p874. 5 indexed citations
18.
Fuhr, Rainard, H Magnussen, David Singh, et al.. (2011). Patient assessments of ease of use of Genuair® versus Aerolizer® and HandiHaler®. 38. 3979. 4 indexed citations
19.
Singh, David, Eugenio Cingolani, George Diamond, & Sanjay Kaul. (2010). Dronedarone for Atrial Fibrillation. Journal of the American College of Cardiology. 55(15). 1569–1576. 21 indexed citations
20.
Singh, David & Steven Singh. (2010). Emerging drugs for atrial fibrillation. Therapy. 7(2). 125–132.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026